Nutex Health (NASDAQ:NUTX) Trading Up 7.5% – Still a Buy?

Nutex Health Inc. (NASDAQ:NUTX)’s stock price rose 7.5% on Monday . The company traded as high as $161.23 and last traded at $159.9170. Approximately 164,047 shares traded hands during mid-day trading, an increase of 2% from the average daily volume of 160,240 shares. The stock had previously closed at $148.79.

Analyst Upgrades and Downgrades

NUTX has been the topic of a number of recent analyst reports. Weiss Ratings restated a “hold (c)” rating on shares of Nutex Health in a research note on Monday, December 29th. Wall Street Zen raised shares of Nutex Health from a “buy” rating to a “strong-buy” rating in a report on Friday, November 28th. Two investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $252.50.

Nutex Health Stock Up 8.4%

The company has a debt-to-equity ratio of 0.67, a current ratio of 3.20 and a quick ratio of 3.18. The firm’s 50-day moving average price is $160.09 and its 200 day moving average price is $122.42. The firm has a market capitalization of $1.14 billion, a price-to-earnings ratio of 8.72 and a beta of -0.01.

Nutex Health (NASDAQ:NUTX) last posted its quarterly earnings data on Tuesday, November 18th. The company reported $7.76 earnings per share (EPS) for the quarter, topping the consensus estimate of ($5.43) by $13.19. The business had revenue of $243.99 million for the quarter, compared to analysts’ expectations of $221.93 million. Nutex Health had a return on equity of 37.44% and a net margin of 11.62%.

Insider Activity at Nutex Health

In other news, CFO Jon Christian Bates acquired 750 shares of the business’s stock in a transaction on Tuesday, November 25th. The shares were purchased at an average price of $136.71 per share, for a total transaction of $102,532.50. Following the completion of the purchase, the chief financial officer directly owned 5,638 shares of the company’s stock, valued at $770,770.98. This represents a 15.34% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 36.92% of the company’s stock.

Hedge Funds Weigh In On Nutex Health

Institutional investors have recently modified their holdings of the company. BNP Paribas Financial Markets boosted its position in Nutex Health by 966.7% during the 2nd quarter. BNP Paribas Financial Markets now owns 320 shares of the company’s stock worth $40,000 after acquiring an additional 290 shares during the period. State of Alaska Department of Revenue acquired a new stake in shares of Nutex Health during the third quarter valued at approximately $30,000. Ameritas Investment Partners Inc. purchased a new position in shares of Nutex Health during the second quarter valued at $44,000. KLP Kapitalforvaltning AS increased its holdings in shares of Nutex Health by 66.7% in the 3rd quarter. KLP Kapitalforvaltning AS now owns 1,500 shares of the company’s stock valued at $155,000 after purchasing an additional 600 shares during the period. Finally, Police & Firemen s Retirement System of New Jersey purchased a new stake in Nutex Health in the 2nd quarter worth approximately $97,000. Institutional investors own 5.32% of the company’s stock.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight?loss services and behavioral health support. By combining in?person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost?effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail?anchored centers, offering treatment for non?life?threatening injuries and illnesses, preventive screenings and basic primary care.